TALARIS THERAPEUTICS INC's ticker is TALS and the CUSIP is 87410C104. A total of 55 filers reported holding TALARIS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $245,735 | +321.0% | 8,745 | -54.5% | 0.00% | – |
| Q2 2023 | $58,365 | +48.2% | 19,199 | -8.4% | 0.00% | – |
| Q1 2023 | $39,395 | -3.2% | 20,955 | -47.5% | 0.00% | – |
| Q4 2022 | $40,682 | -52.1% | 39,884 | +23.4% | 0.00% | – |
| Q3 2022 | $85,000 | -22.7% | 32,314 | +32.3% | 0.00% | – |
| Q2 2022 | $110,000 | -54.9% | 24,425 | -1.6% | 0.00% | – |
| Q1 2022 | $244,000 | -30.9% | 24,821 | +7.5% | 0.00% | – |
| Q4 2021 | $353,000 | – | 23,088 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 682,923 | $10,032,000 | 1.61% |
| SECTORAL ASSET MANAGEMENT INC | 711,000 | $10,445,000 | 0.84% |
| Logos Global Management LP | 507,923 | $7,461,000 | 0.63% |
| Artal Group S.A. | 2,064,262 | $30,324,000 | 0.62% |
| Cormorant Asset Management, LP | 1,215,847 | $17,264,000 | 0.59% |
| Eventide Asset Management | 1,561,092 | $22,411,000 | 0.30% |
| Blackstone Inc. | 8,089,315 | $118,832,000 | 0.27% |
| Avidity Partners Management LP | 436,363 | $6,410,000 | 0.17% |
| VIKING GLOBAL INVESTORS LP | 3,289,617 | $48,324,000 | 0.15% |
| HHLR ADVISORS, LTD. | 853,344 | $12,536,000 | 0.13% |